This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Mar;159(3):608.

doi: 10.1016/j.ajo.2014.12.016.

Reply: To PMID 25068637

Affiliations

Affiliations

¹ Nagoya, Japan.
² Kiel, Germany.
³ Bordeaux, France.
⁴ Bonn, Germany.
⁵ Vienna, Austria.
⁶ Tarrytown, New York.
⁷ Berlin, Germany.
⁸ Berlin, Germany and Erlangen-Nürnberg, Germany.
⁹ Berlin, Germany and Hamburg, Germany.
¹⁰ Berlin, Germany and Düsseldorf, Germany.

PMID: 25681024
DOI: 10.1016/j.ajo.2014.12.016

Comment

Reply: To PMID 25068637

Yuichiro Ogura et al. Am J Ophthalmol. 2015 Mar.

. 2015 Mar;159(3):608.

doi: 10.1016/j.ajo.2014.12.016.

Affiliations

¹ Nagoya, Japan.
² Kiel, Germany.
³ Bordeaux, France.
⁴ Bonn, Germany.
⁵ Vienna, Austria.
⁶ Tarrytown, New York.
⁷ Berlin, Germany.
⁸ Berlin, Germany and Erlangen-Nürnberg, Germany.
⁹ Berlin, Germany and Hamburg, Germany.
¹⁰ Berlin, Germany and Düsseldorf, Germany.

PMID: 25681024
DOI: 10.1016/j.ajo.2014.12.016

No abstract available

PubMed Disclaimer

Comment on

Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study.
Ogura Y, Roider J, Korobelnik JF, Holz FG, Simader C, Schmidt-Erfurth U, Vitti R, Berliner AJ, Hiemeyer F, Stemper B, Zeitz O, Sandbrink R; GALILEO Study Group. Ogura Y, et al. Am J Ophthalmol. 2014 Nov;158(5):1032-8. doi: 10.1016/j.ajo.2014.07.027. Epub 2014 Jul 25. Am J Ophthalmol. 2014. PMID: 25068637 Clinical Trial.
Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study.
Călugăru D, Călugăru M. Călugăru D, et al. Am J Ophthalmol. 2015 Mar;159(3):607-8. doi: 10.1016/j.ajo.2014.12.011. Am J Ophthalmol. 2015. PMID: 25681022 No abstract available.

Similar articles

Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study.
Călugăru D, Călugăru M. Călugăru D, et al. Am J Ophthalmol. 2015 Mar;159(3):607-8. doi: 10.1016/j.ajo.2014.12.011. Am J Ophthalmol. 2015. PMID: 25681022 No abstract available.
Intravitreal ziv-aflibercept for recurrent macular edema secondary to central retinal venous occlusion.
Chhablani J. Chhablani J. Indian J Ophthalmol. 2015 May;63(5):469-70. doi: 10.4103/0301-4738.159909. Indian J Ophthalmol. 2015. PMID: 26139820 Free PMC article. No abstract available.
One-year treatment outcomes of ziv-aflibercept for treatment-naïve macular oedema in branch retinal vein occlusion.
Chan EW, Eldeeb M, Dedhia CJ, Mansour A, Chhablani J. Chan EW, et al. Acta Ophthalmol. 2018 Mar;96(2):e256-e257. doi: 10.1111/aos.13432. Epub 2017 Mar 31. Acta Ophthalmol. 2018. PMID: 28371171 No abstract available.
Aflibercept: A Review in Macular Oedema Secondary to Branch Retinal Vein Occlusion.
Hoy SM. Hoy SM. Drugs Aging. 2017 May;34(5):393-400. doi: 10.1007/s40266-017-0458-6. Drugs Aging. 2017. PMID: 28365905 Review.
Comprehensive Review of Ocular and Systemic Safety Events with Intravitreal Aflibercept Injection in Randomized Controlled Trials.
Kitchens JW, Do DV, Boyer DS, Thompson D, Gibson A, Saroj N, Vitti R, Berliner AJ, Kaiser PK. Kitchens JW, et al. Ophthalmology. 2016 Jul;123(7):1511-20. doi: 10.1016/j.ophtha.2016.02.046. Epub 2016 Apr 12. Ophthalmology. 2016. PMID: 27084563 Review.

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science